Avivagen Inc
- LAST PRICE0.0050
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0050
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Avivagen Inc | 388.5K | -0.1x | --- |
Sunshine Agri Tech Inc | 720.1K | -47.6x | --- |
Imperial Ginseng Products Ltd | 688.7K | 0.2x | -9.31% |
Gourmet Ocean Products Inc | 1.3M | -15.9x | --- |
Affinor Growers Inc | 3.4M | -2.8x | --- |
Ayurcann Holdings Corp | 5.8M | -0.9x | --- |
Company Information
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.
Contact Information
- Headquarters
- 100 Sussex DriveOTTAWA, ON, Canada K1A 0R6
- Phone
- 613-702-2908
- Fax
- 613-993-0796
Executives
- Independent Chairman of the Board
- David Hankinson
- Chief Executive Officer, Vice Chairman of the Board
- G.F. Kym Anthony
- Interim Chief Financial Officer
- Ira Levy
- Executive Vice President - Business Development and Product Innovation
- James Nickerson
- Chief Scientific Officer, Director
- Graham Burton
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $388.5K |
|---|---|
Revenue (TTM) | $715.2K |
Shares Outstanding | 77.7M |
Avivagen Inc does not pay a dividend. | |
Beta | 1.08 |
EPS | $-0.07 |
Book Value | $-0.08 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 0.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -650.75% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
